Advertisement
News
Advertisement

InVivo CEO tells shareholders stock is "undervalued"

Fri, 10/12/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

In a letter to shareholders InVivo Therapeutics Holdings Corp.(NVIV) CEO Frank Reyolds said he believes InVivo’s stock is undervalued and blames the 50 percent decline since the end of August on “unsubstantiated” Internet rumors which claimed Reynolds had sold shares in recent months.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading